Berberine and its derivatives: A patent review (2009-2012)

Expert Opinion on Therapeutic Patents

Volumn 23, Issue 2, 2013, Pages 215-231

  Singh, Inder Pal ^a   Mahajan, Shivani ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anti diabetic; Anti inflammatory; Berberine; Cardiovascular; Therapeutics; Tumor

Indexed keywords

4 [BIS(2 CHLOROETHYL)OXIDOAMINO]PHENYLALANINE; ALKYLATING AGENT; ANDROGRAPHOLIDE; ANGELICIN; BAICALEIN; BAICALIN; BERBERINE; BERBERINE DERIVATIVE; BEROLINE; CELL PENETRATING PEPTIDE; CHLORAMBUCIL; CURCUMIN; DAUNORUBICIN; DOXORUBICIN; ENZYME INHIBITOR; ETHIDIUM BROMIDE; EVODIAMINE; FLUOROURACIL; FLUTAMIDE; GALLIC ACID; GOSSYPOL ACETIC ACID; INTERCALATING AGENT; LYCOPENE; PROFLAVINE; PSORALEN; QUERCETIN; RUTAECARPINE; THALIDOMIDE; TRIPTOLIDE; UNINDEXED DRUG;

ACNE VULGARIS; ALLERGIC DISEASE; ANTINEOPLASTIC ACTIVITY; APPENDICITIS; CANCER INHIBITION; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; COLON CANCER; DEPRESSION; DIABETES MELLITUS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; ECZEMA; HUMAN; HYPERTENSION; IC 50; INFECTION; INFLAMMATION; INTESTINE POLYP; METABOLIC DISORDER; NEOPLASM; NONHUMAN; OVARY POLYCYSTIC DISEASE; PATENT; PELVIC INFLAMMATORY DISEASE; REVIEW; RHEUMATOID ARTHRITIS; TABLET FORMULATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BERBERINE; CARDIOVASCULAR AGENTS; DRUG DESIGN; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR STRUCTURE; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84872724395     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2013.746314     Document Type: Review

References (106)

1. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008;22:999-1012
2. Fan S. Application of berberine in preparing tumor radio sensitization medicine. CN101816653; 2010
3. Wang B, Fang W, Yan F, et al. Application of berberine to preparing drug for preventing and treating familial adenomatous polyposis. CN102058590; 2011
4. Land H, McMurray HR, Sampson ER. Methods and compositions related to synergistic responses to oncogenic mutations. US20120114670; 2012
5. Kelley S, Pereira M, Fonseca S. Mitochondrial penetrating peptides as carriers for anticancer compounds. WO2011150494; 201
6. Wang Y, Du E, Xu L, et al. Andrographolide and berberine combination and its application thereof. CN102151260; 2011
7. Wang H, Lv X, Lu D, et al. Application of berberine and doxorubicin mixed preparation in preparation of medicament against doxorubicin cardiac dysfunction and tumor. CN102008495; 2011
8. Tao X, Chen P, Chen R, et al. Medicinal composition for colon cancer and method for preparing effective monomers thereof. CN101978962; 2011
9. Shih M, Chao Y, Shih Y, et al. Plant derived compounds and compound formulae containing the same for the treatment of cervical cancer. US20090137661; 2009
10. Mascarenhas D. Metal-binding therapeutic peptides. US20090053203; 2009
11. Zhang Q. Pharmaceutical composition for the treatment of pelvic inflammation. CN102302505; 2012
12. Jiao C. Cream for treating acne. CN102038732; 2011
13. Tong R, Zeng M, Zhu J, et al. Pharmaceutical composition for preventing and curing acnes and application thereof. CN101637470; 2010
14. Yu S, Yu R. Non-invasive method for radical treatment of appendicitis by subcutaneously injecting auricular point of appendix. CN102451259; 2012
15. Zhang W, Dou S, Liu R, et al. Pharmaceutical composition for preventing and treating rheumatoid arthritis. CN101700249; 2010
16. Yang Z, He Q, Liu X, et al. Traditional Chinese medicinal nano-cream for treating chronic eczema. CN102178731; 2011
17. Yang Z, He Q, Liu X, et al. Chinese medicine nanoemulsion spraying agent for treating chronic eczema. CN102178732; 2011
18. Li Q. Medicinal liquid for treating burn and scald. CN101732368; 2010
19. Filippini A, Riccioli A, Paone A, et al. Combination of hypoxia-inducible factor-1 inhibitors and toll-like receptor-3 agonists for treating solid tumors. WO2011128436; 2011
20. Tao X. Pharmaceutical pill for treating diarrhea and gastroenteritis. CN102370930; 2012
21. Gao Y, Wang H. Traditional Chinese medicine composition for treating acute enteritis. CN102370926; 2012
22. Huang X. Chinese-western medical capsule for treating chronic enteritis and its formulation. CN102327426; 2012
23. Sun J. Composite medicine preparation for treating gastro-enteritis and gastric ulcer. CN101579340; 2009
24. Yang X. Chinese medicine for promoting digestion. CN101406484; 2009
25. Colman J. Combinations of berberine, artemisinin, loperamide and their derivatives to treat malaria, diarrhea, travellers' diarrhea dysentery, dengue fever, parasites, cholera and viruses. WO2012108892; 2012
26. Wu J, Tao J, Zhu Y, et al. Application of berberine in medicament for treating hepatitis B virus infection. CN101642454; 2010
27. Meng H, Wang J, Song X, et al. Prescription of compound external-use ulcer powder. CN101352450; 2009
28. Huang S, Chung W, Chang T. Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders. WO2011000218; 2011
29. Meng H, Shi Q, Jiang M, et al. Synthesis of tubercle bacillus resistant medicament 3-alkoxyl-8-alkyl-12-R3-jatrorrhizine salt and uses thereof. CN101367800; 2009
30. Zeng QS. Composition and regimen for the treatment of herpes simplex and herpes zoster primarily by eliminating their pathogenetic conditions and taking into account both pathogenesis and etiology. US7862838; 2011
31. Xie Y, Yu H. Nanomedicine composition for resisting primary bronchitis virus and preparation method thereof. CN101856453; 2010
32. Wu J, Tao J, Zhu Y, et al. Application of berberine in medicine for treating or preventing influenza virus. CN101829113; 2010
33. Wen W. Method for preparing vaginal effervescent tablet for treatment of vaginitis. CN102335229; 2012
34. Luo C. Suppository for treating gynecologic diseases and preparation method thereof. CN101455715; 2009
35. Xia P, Xiong X. Medicine for treating hemorrhoids and preparation method thereof. CN101628045; 2010
36. Li D, Wen X, Zhu G. Anti-human papilloma virus (anti-HPV) external effervescent tablet and preparation method and application thereof. CN101518574; 2009
37. Ling P, Chen J, He Y, et al. Drug composite and application thereof. CN101961344; 2011
38. Li X. Drops for treating pink eye. CN101947226; 2011
39. Fang J. Plant extract composition for killing fungi, preparation method thereof and application in preparing antifungal products. CN101559035; 2009
40. Letaka T. Composition for protecting gastric mucosa, composition for urease activity inhibition, and pharmaceutical preparation comprising the compositions as active ingredients. JP2012097072; 2012
41. Tan G, Yang S, Tan Y. Oil for burn. CN101468073; 2009
42. Guan Y, Yan D. Pharmaceutical composition for treating angiocardiopathy. CN101664407; 2010
43. Ashrafian H, Watkins H. Treatment of heart failure. US20100008908; 2010
44. Guan Y, Yan D. Composition for reducing blood pressure. CN101623294; 2010
45. Wang X, Xu M, Wang S, et al. Method for treating or diagnosing heart failure or tendency of heart failure or improving functions of myocardial cells by miR-24 (MicroRNA-24). CN102242080; 2011
46. Chen L, Li J, Lv X. Medicament composition for treating sugar diabetes. CN101574343; 2009
47. Tong X. Product for preventing and/or treating diabetes. CN102166239; 2011
48. Young J. Method of treating non-insulin dependent diabetes mellitus and related complications. US20100292178; 2010
49. Chen X. Medicinal composition for reducing blood sugar and blood lipid and treating diabetes. CN101601684; 2009
50. Davies G, Hu Y. Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs. WO2011119649; 2011
51. Park DS, Lee JD, Baek YH, et al. Medicinal plant extracts for the prevention and treatment of bone diseases. KR2011032446; 2011
52. Tsunoda Y. Kato Y. contraceptive drug containing extracts of Coptis rhizome and Phellodendron bark, or berberine or salt thereof, and birth control method using them. JP2011088874; 2011
53. Deng Y, Xu Y, Zhang X. Berberine liposome and preparation method thereof. CN102475682; 2012
54. Sommerfeld M, Schaefer H, Boscheinen O, et al. Pharmaceutical composition for treating a metabolic syndrome. EP2359843; 2011
55. Jia B. Application of berberine ion pair compound in antitumor agent. CN102309483; 2012
56. Li Q, Zu Y, He W, et al. New derivatives of berberine coupled with cholic acid at ninth position through ester bond and preparation methods thereof. CN102229636; 2011
57. Li Q, Zu Y, He W, et al. New derivative bonded by berberine and cholic acid at 9th position of berberine and preparation method thereof. CN102225962; 2011
58. Lombardi P, Buzzetti F, Arcamone AG. Benzoquinolizinium salt derivatives as anticancer agents. WO2011009714; 2011
59. Yang Q, Yu C, Kuang C, et al. Application of berberine and derivatives thereof in preparation of indole amine 2, 3-dioxygenase inhibitor. CN101843618; 2010
60. Leblond B, Beausoleil E, Chauvignac C, et al. Compounds and methods for modulating RHO GTPases. WO2009007457; 2009
61. Zhang Z, Shao L, Shen Y. New medicine combination for treating enteritis and bacillary dysentery. CN101548979; 2009
62. Nakamura T, Muraoka K. Granular agent having masked bitter taste and disagreeable taste of galenicals and intraorally rapidly disintegrating tablet. JP2012056859; 2012
63. Liu W, Gao Y. Berberine tannate dispersible tablet and preparation method thereof. CN101884625; 2010
64. Wang D, Shao K, Zhang L. Synthetic method of berberine 13-bit derivant and berberrubine 13-bit derivant. CN101665491; 2010
65. Li X, Ye X, Yuan L. Synthesis of tubercle bacillus resistant medicament 3-alkoxyl-8-alkyl-12-R3-jatrorrhizine salt and uses thereof. CN101367800; 2009
66. Kamei E. Pharmaceutical composition. JP2011213667; 2011
67. Zhang H, Hong Y. Berberine-oryzanol conjugate derivative and synthetic method and medical application. CN102295675; 2011
68. Zhang H. Berberine-oryzanol compound, and preparation method and application thereof. CN102250186; 2011
69. Skulachev MV, Skulachev VP, Zamyatin AA, et al. Pharmaceutical substances on the basis of mitochondrially addressed antioxidants. WO2011059355; 2011
70. Song C. Method for producing berberine by culturing Coptis chinensis Franch suspended cells. CN102399217; 2012
71. Shang S, Xu M, Li Y, et al. Method for synthesizing berberine citrate. CN101948469; 2011
72. Hu L, Li J, Zhang H, et al. 8,8-disubstituted-13,13a-dihyrdroberberine derivative as well as pharmaceutical composition and application thereof. CN101870694; 2010
73. Liu H, Li G, Wang J, et al. Berberine derivatives useful for modulating lipid levels and their methods of synthesis. WO2011006000; 2011
74. Teng H, Wu W. Mangiferin-berberine salt, manufacturing method and use thereof. WO2010145192; 2010
75. Wu S, Zhu H, Chen S, et al. Brominated N-O-methoxycarbonylbenzyl tetrahydroberberine and application thereof in treatment of hyperlipidemia. CN102040603; 2011
76. Wang P, Wu X. Berberine glycyrrhetinic acid enantiomeric salts and preparation method and application thereof. CN101935334; 2011
77. Lippa AS. Methods and compositions for the treatment of metabolic and cardiovascular disorders. WO2010104595; 2010
78. Qin Y, Cui G. Compound for controlling autoimmune disease and use thereof. CN101919844; 2010
79. Li X, Huang L, Shi A, et al. Preparation method and application of 9-bit substituent double-functional group berberine derivatives. CN102030746; 2011
80. Zhang X, Zhang J, Deng Y, et al. Tannin berberine gel for treating cervical erosion and preparation process thereof. CN102028873; 2011
81. Zhou X. Fang Bo, Tao L, et al. Berberine-phenylacetic acid derivative and pharmaceutically acceptable salt and application thereof. CN102342935; 2012
82. Zhou X. Fang Bo, Tao L. Application of berberine-phenylacetic acid derivatives or their salts in preparing antimicrobial drugs. CN102342939; 2012
83. Li Y. Chinese medicinal composition for dispelling bruise and dissolving tumor. CN101347525; 2009
84. Ding G, Meng Z, Cao L. External-use Chinese medicinal composition formulation and uses thereof. CN101406564; 2009
85. Zhao C. Method for controlling quality of dermatosis toxemia preparation. CN101513467; 2009
86. Wang S, Liu M, Huangfu M, et al. Chinese medicinal adhesive plaster. CN101850094; 2010
87. Ma Q, Wang Q, Sun J. Compound agrimony enteritis tablet and quality detection method thereof. CN101480455; 2009
88. Tang M, Jiang P. Traditional Chinese medicine composition for treating infantile dyspepsia and its preparation method and quality control method. CN102293948; 2011
89. Zhou Q, Pi H, Luo Y, et al. Quality control method of Chinese medicinal preparation for treating urinary infection. CN101874845; 2010
90. Zhu Z, Bai S, Li L. Anti-erosive suppository for treating gynecological infection and preparation method thereof. CN102085266; 2011
91. Gastaminza P, Chisari F. Sigma 1 receptor inhibition as a novel therapeutical approach against hepatitis C virus infection. WO2010101649; 2010
92. Zabrecky G. Methods and formulations for treating chronic liver disease. WO2010040058; 2010
93. Xiong L. Application method of amur cork for preparing digestive ulcer medicament. CN101637527; 2010
94. Tang X, Li C. Compound capsule containing root of red-rooted salvia and preparation method and quality determination method thereof. CN101780170; 2010
95. Jiang Z, Tian H, Wang S. Content measuring method and discriminating method for pharmaceutical composition preparation. CN101953915; 2011
96. Shan JJ, Ling L, Goel V, et al. Pharmaceutical composition comprising extracts of HuangLian and ku ding cha effective for lowering blood lipid levels. WO2009133458; 2009
97. Guo J. Plant extract composition for preventing and treating arteriosclerosis and preparation method thereof. CN102160876; 2011
98. Lai X, Meng X, Zhang Y, et al. Wine-steamed Chinese goldthread processed product as well as preparation method and application thereof. CN101874832; 2010
99. Zhou M, Zhao A, Jia W, et al. Composition of Chinese medicine extract for treating diabetes. CN101433607; 2009
100. Guo J, Bei W, Zang L, et al. Composition of plant extracts for preventing or curing metabolism disorder of blood lipid and application thereof. CN101444549; 2009
101. Wang W, Han J, Ni J, et al. Traditional Chinese medicine compound and preparation method thereof. CN102078397; 2011
102. Chen Z, Sun W. Weight-losing medicament formed by matching alpha-ricinoleic acid ethyl ester with berberine. CN101879162; 2010
103. Hu S, Li J, Yao G, et al. Traditional Chinese medicine composition for treating precocious puberty and preparation and quality inspection method thereof. CN102114226; 2011
104. Fu L, Fu J. Chinese medicinal composition for treating syphilis infection as well as preparation method and quality control method thereof. CN101485817; 2009
105. Chu J, Song J. Method for preparing Chinese medicinal oral liquid for treating attention deficit hyperactivity disorder. CN101879268; 2010
106. Li J, Shi L. Method for manufacturing traditional Chinese medicine preparation for treating chronic renal failure. CN102488805; 2012.